Qiang Qin

机构：Guangzhou University of Chinese Medicine · ORCID：0000-0002-4064-7592

发表论文 33 篇 · 总被引 715 次 · h-index 12

代表论文

• Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis (2018 · Journal of Experimental & Clinical Cancer Research · 被引 273)
• The inhibitor effect of RKIP on inflammasome activation and inflammasome-dependent diseases (2020 · Cellular and Molecular Immunology · 被引 41)
• The immune-related gene CD52 is a favorable biomarker for breast cancer prognosis (2021 · Gland Surgery · 被引 32)
• Downregulated NDR1 protein kinase inhibits innate immune response by initiating an miR146a-STAT1 feedback loop (2018 · Nature Communications · 被引 32)
• Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial (2022 · EClinicalMedicine · 被引 27)
• Stk24 protects against obesity-associated metabolic disorders by disrupting the NLRP3 inflammasome (2021 · Cell Reports · 被引 23)